Nantahala Capital Management, LLC Cue Biopharma, Inc. Transaction History

Nantahala Capital Management, LLC

$1.68 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.1 $116 - $210	-68 Reduced 0.25%	26,692 $70,000
Q2 2023 Aug 14, 2023	SELL	$3.11 - $4.91 $206,930 - $326,696	-66,537 Reduced 71.32%	26,760 $97,000
Q3 2022 Nov 10, 2022	SELL	$2.23 - $3.37 $15,982 - $24,152	-7,167 Reduced 7.13%	93,297 $208,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $5.34 Million - $12.7 Million	-2,143,895 Reduced 95.52%	100,464 $250,000
Q1 2022 May 13, 2022	SELL	$4.41 - $12.28 $1.3 Million - $3.63 Million	-295,341 Reduced 11.63%	2,244,359 $11 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $340,808 - $560,168	-31,382 Reduced 1.22%	2,539,700 $28.7 Million
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $1.07 Million - $1.63 Million	-106,584 Reduced 3.98%	2,571,082 $37.5 Million
Q2 2021 Aug 16, 2021	SELL	$10.9 - $14.53 $286,855 - $382,386	-26,317 Reduced 0.97%	2,677,666 $31.2 Million
Q1 2021 May 14, 2021	BUY	$11.2 - $16.09 $2.21 Million - $3.17 Million	197,211 Added 7.87%	2,703,983 $33 Million
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $1.83 Million - $2.7 Million	164,556 Added 7.03%	2,506,772 $31.4 Million
Q3 2020 Nov 16, 2020	BUY	$15.05 - $23.54 $253,261 - $396,131	16,828 Added 0.72%	2,342,216 $35.3 Million
Q2 2020 Aug 14, 2020	SELL	$12.7 - $30.73 $2.27 Million - $5.48 Million	-178,452 Reduced 7.13%	2,325,388 $57 Million
Q1 2020 May 14, 2020	BUY	$9.85 - $22.27 $10.8 Million - $24.5 Million	1,098,899 Added 78.22%	2,503,840 $35.5 Million
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $188,805 - $467,200	26,743 Added 1.94%	1,404,941 $22.3 Million
Q2 2019 Aug 14, 2019	BUY	$7.18 - $9.65 $3.59 Million - $4.83 Million	500,100 Added 56.95%	1,378,198 $12.4 Million
Q4 2018 Feb 14, 2019	BUY	$4.35 - $8.73 $108,749 - $218,250	25,000 Added 2.93%	878,098 $4.13 Million
Q3 2018 Nov 14, 2018	BUY	$7.91 - $11.89 $3.4 Million - $5.11 Million	429,518 Added 101.4%	853,098 $7.72 Million
Q2 2018 Aug 14, 2018	BUY	$10.93 - $14.48 $4.63 Million - $6.13 Million	423,580 New	423,580 $5.02 Million

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account